MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-08-2025
Surmodics Depreciation & Amortization 2011-2026 | SRDX
Annual Depreciation & Amortization Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.69 M | 8.52 M | 9.14 M | 8.02 M | 7.26 M | 7.31 M | 6.43 M | 5.56 M | 4.87 M | 2.8 M | 2.72 M | 2.89 M | 2.93 M | 3.16 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.14 M | 2.72 M | 5.74 M |
Quarterly Depreciation & Amortization Surmodics
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.1 M | 2.14 M | 2.08 M | - | 2.13 M | 2.1 M | 2.33 M | - | 2.15 M | 2.09 M | 2.12 M | - | 2.21 M | 2.32 M | 2.38 M | - | 1.84 M | 1.91 M | 1.86 M | 5.39 M | 1.79 M | 1.86 M | 1.8 M | 5.46 M | 1.89 M | 1.8 M | 1.76 M | 4.71 M | 1.6 M | 1.76 M | 1.52 M | 4.01 M | 1.4 M | 1.52 M | 1.28 M | 3.7 M | 1.41 M | 1.28 M | 909 K | 2.08 M | 694 K | 909 K | 683 K | 2.05 M | 674 K | 683 K | 697 K | 2.17 M | 728 K | 697 K | 722 K | 2.21 M | 734 K | 722 K | 749 K | 2.39 M | 789 K | 749 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.46 M | 674 K | 1.85 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
321 M | $ 115.69 | 0.13 % | $ 35.2 B |  USA |
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Illumina
ILMN
|
354 M | $ 128.66 | 0.61 % | $ 20.5 B | USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
1.11 M | $ 1.66 | -0.9 % | $ 2.21 M | USA |
 |
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
70.1 M | $ 84.24 | -0.11 % | $ 5.69 B | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 417.83 | 1.78 % | $ 12.1 B | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 24.81 | 1.43 % | $ 689 M | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
15 M | $ 21.33 | 0.47 % | $ 1.14 B | USA |
 |
Senseonics Holdings
SENS
|
1.51 M | $ 7.17 | 1.7 % | $ 299 M | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Soleno Therapeutics
SLNO
|
2.02 M | $ 52.75 | 0.06 % | $ 2.68 B | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 15.7 | -3.74 % | $ 475 M | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M |  China |
 |
Thermo Fisher Scientific
TMO
|
1.05 B | $ 467.48 | -0.45 % | $ 176 B | USA |
 |
Charles River Laboratories International
CRL
|
403 M | $ 171.6 | 1.08 % | $ 8.51 B | USA |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 61.18 | 0.39 % | $ 3.66 B | USA |
 |
Guardant Health
GH
|
39.7 M | $ 89.01 | 0.11 % | $ 11.2 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
425 K | $ 1.93 | -2.08 % | $ 8.54 M | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
119 M | $ 9.58 | 0.42 % | $ 2.08 B | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.15 | 0.7 % | $ 4.94 M | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 17.19 | -0.23 % | $ 385 M | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 101.81 | -0.35 % | $ 8.4 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
681 M | $ 263.75 | - | $ 21.9 B | USA |
 |
Celcuity
CELC
|
167 K | $ 124.21 | 2.62 % | $ 5.81 B | USA |
 |
OpGen
OPGN
|
175 K | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
36.1 M | $ 8.48 | 2.29 % | $ 1.09 B | USA |
 |
Myriad Genetics
MYGN
|
53.7 M | $ 4.79 | 0.21 % | $ 444 M | USA |
 |
Natera
NTRA
|
16.7 M | $ 204.22 | 0.23 % | $ 20.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
570 M | $ 196.35 | 0.07 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
405 M | - | -0.91 % | $ 14.7 B | USA |